AHK-Cu Research: ATCUN Copper Chemistry and Comparative Peptide Pharmacology

AHK-Cu (Ala-His-Lys copper complex) is a synthetic tripeptide incorporating Cu(II) coordinated through the ATCUN (Amino Terminal Copper and Nickel) binding motif. Structurally related to GHK-Cu (Gly-His-Lys copper complex), AHK-Cu provides a direct pharmacological comparator for investigating the role of the N-terminal amino acid in ATCUN copper coordination chemistry and downstream biological activity.

The ATCUN Motif and Copper Coordination

The ATCUN (Amino Terminal Copper and Nickel) motif is defined by the sequence X-X-His at the N-terminus of a peptide, where the first two positions can be any amino acid but histidine must occupy position 3. Cu(II) is coordinated in a square planar geometry by four nitrogen donors: the N-terminal primary amine, the deprotonated amide nitrogen between residues 1 and 2, the deprotonated amide nitrogen between residues 2 and 3, and the imidazole nitrogen of His3. This square planar N4 coordination is highly stable (stability constant log K approximately 16 for GHK-Cu) and produces the characteristic blue-green colour of ATCUN-Cu complexes through Cu(II) d-d electronic transitions in the visible spectrum.

Both GHK (Gly-His-Lys) and AHK (Ala-His-Lys) satisfy the ATCUN requirement — His at position 3, free N-terminus. The structural difference is solely at position 1: glycine (H side chain, achiral) versus alanine (methyl side chain, chiral L-configuration). This single methyl group addition introduces steric bulk adjacent to the N-terminal coordination site, potentially altering the geometry of copper coordination and the resulting EPR and UV-visible spectroscopic signature.

Copper Coordination Chemistry Research

EPR Spectroscopy: The definitive characterisation of ATCUN copper coordination uses X-band EPR (9.5 GHz, 77K or liquid helium temperature for frozen solutions). Square planar Cu(II) in ATCUN complexes shows an axial spectrum with g-parallel approximately 2.18-2.22 and four-line copper hyperfine splitting (A-parallel approximately 180-200 × 10^-4 cm^-1). Comparing EPR parameters between GHK-Cu and AHK-Cu directly quantifies how the Gly1→Ala1 substitution affects Cu(II) coordination geometry. Any change in A-parallel indicates a change in the equatorial donor set geometry that may affect copper's redox chemistry.

UV-Visible Spectroscopy: Both GHK-Cu and AHK-Cu should show d-d transition absorption bands between 600-700nm. Prepare equimolar solutions (1-5mM) in 50mM HEPES pH 7.4. Scan 400-900nm. Compare lambda-max and extinction coefficient between the two complexes — a shift in lambda-max indicates a change in ligand field strength attributable to the N-terminal residue difference.

Cyclic Voltammetry: The Cu(II)/Cu(I) redox potential of ATCUN complexes is pharmacologically important — lower reduction potential means more stable Cu(II), less likely to undergo Fenton chemistry. Compare CV traces for GHK-Cu and AHK-Cu in phosphate buffer pH 7.4 using a glassy carbon working electrode. The half-wave potential difference (if any) characterises whether the Ala1 versus Gly1 difference affects copper redox chemistry.

Stability Constant Determination: Competitive chelation against a reference ligand of known stability constant (e.g., nitrilotriacetic acid, NTA) allows indirect determination of AHK-Cu stability constant by UV-vis monitoring of the competition equilibrium. Compare with published GHK-Cu stability constant (log K approximately 16.2) to quantify the effect of the N-terminal amino acid on overall copper binding affinity.

Comparative Biological Research

Fibroblast collagen synthesis: Primary human dermal fibroblasts in DMEM + 10% FBS. Four treatment groups: vehicle, GHK-Cu (0.1-100nM), AHK-Cu (0.1-100nM), CuSO4 alone (matching copper concentration). 72-hour treatment. Measure procollagen type I C-propeptide (PICP) by ELISA in conditioned medium and COL1A1/COL1A2 mRNA by RT-PCR. Any difference in collagen synthesis between GHK-Cu and AHK-Cu at matched copper concentrations is attributable to the peptide sequence difference (Gly versus Ala at position 1).

SP1 transcription factor activation: GHK (and by extension GHK-Cu) has been proposed to activate SP1 transcription factor, driving expression of growth factors and ECM proteins. SP1-responsive luciferase reporter assay in fibroblasts (transiently transfected with 3×SP1-pGL3) comparing GHK-Cu and AHK-Cu at matched concentrations characterises whether SP1 activation is Gly1-specific or is a shared ATCUN property.

Wound healing scratch assay: Confluent fibroblast monolayers, scratch with sterile pipette tip, treat with GHK-Cu or AHK-Cu (0.1-100nM) in serum-free medium. Image at 0, 12, and 24 hours. Measure wound area by automated image analysis. Compare migration rate between treatments.

Key Published Research

• Pickart L, Vasquez-Soltero JM, Margolina A. "GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration." BioMed Research International, 2015. PMID: 25883971
• Camponeschi F, et al. "Metal binding properties of short peptides based on the ATCUN motif." Inorganic Chemistry, 2013.
• Harford C, Sarkar B. "Amino terminal Cu(II)- and Ni(II)-binding (ATCUN) motif of proteins and peptides." Accounts of Chemical Research, 1997. PMID: 9276864

View AHK-Cu (Copper Tripeptide) →

For laboratory and analytical research purposes only. Not for human or veterinary use.

AHK-Cu in Wound Biology Research

Copper peptides have established roles in wound healing biology through multiple mechanisms: direct fibroblast stimulation, angiogenesis promotion, and anti-inflammatory effects. AHK-Cu and GHK-Cu both provide copper delivery to the wound microenvironment alongside peptide sequence-specific biological signals. Comparing these two copper peptides in wound healing research characterises whether the N-terminal residue identity affects wound healing pharmacology.

For in vitro wound healing comparison: use a three-cell-type co-culture model incorporating keratinocytes (HaCaT or primary NHEKs), fibroblasts (primary human dermal fibroblasts), and endothelial cells (HUVECs) in a transwell co-culture system. Wound the keratinocyte monolayer with a scratch, then add AHK-Cu, GHK-Cu, or CuSO4 (matched copper concentration) to the culture medium. Image wound at 0, 8, and 24 hours. Measure: keratinocyte migration rate (wound closure); HUVEC tube formation in Matrigel at 24 hours (angiogenic response); and fibroblast collagen synthesis (PICP ELISA from co-culture conditioned medium). Any difference between AHK-Cu and GHK-Cu in this multi-cell wound model isolates the N-terminal residue contribution to the wound healing pharmacology of ATCUN copper peptides.

AHK-Cu and Melanin Research

MC1R activation in melanocytes drives eumelanin synthesis — brown/black melanin that provides UV photoprotection. GHK-Cu has been shown to modulate melanin synthesis in some published research, proposed through effects on tyrosinase (the rate-limiting melanogenic enzyme) activity. Testing AHK-Cu alongside GHK-Cu in melanocyte melanin synthesis assays allows pharmacological comparison.

Human primary melanocytes or MNT-1 melanoma cells treated with AHK-Cu versus GHK-Cu (0.1-100nM) for 72 hours. Measure melanin content (NaOH dissolution, absorbance 405nm versus synthetic melanin standard), tyrosinase activity (L-DOPA oxidation assay in cell lysate), and MITF expression (Western blot — MITF is the master transcription factor for melanogenic gene expression). Any difference in melanogenic activity between AHK-Cu and GHK-Cu at matched copper concentrations characterises the Gly versus Ala N-terminal residue contribution to melanocyte pharmacology of ATCUN copper peptides.

AHK-Cu and Antioxidant Research

Copper in the ATCUN complex exists in the Cu(II) oxidation state. Cu(II) ATCUN complexes have both pro-oxidant and antioxidant properties depending on the reaction context. As a Fenton-chemistry catalyst, Cu(II) can react with H2O2 to generate hydroxyl radical (.OH) — a highly reactive ROS. However, ATCUN Cu(II) complexes also show superoxide dismutase (SOD)-like activity, catalytically converting two superoxide anions to H2O2 and O2. The balance between these pro- and antioxidant activities in specific biological contexts is a research question that AHK-Cu and GHK-Cu allow to be systematically addressed.

For comparative pro-oxidant/antioxidant research: test AHK-Cu versus GHK-Cu versus CuSO4 at matched copper concentrations in the presence of H2O2 and a hydroxyl radical detector (coumarin-3-carboxylic acid, which forms 7-hydroxycoumarin fluorescent product upon .OH attack). Increased fluorescence indicates greater .OH generation (Fenton chemistry). Separately, test in the cytochrome c reduction assay for SOD-like activity — SOD-mimetic compounds inhibit cytochrome c reduction by superoxide generated by xanthine/xanthine oxidase. If AHK-Cu shows different Fenton chemistry and SOD-mimetic profiles than GHK-Cu despite identical copper coordination geometry, this would indicate that the N-terminal residue affects the copper's redox biology beyond coordination geometry alone.

In cell-based oxidative stress research: treat human dermal fibroblasts with 200µM H2O2 (30 minutes) to induce oxidative stress. Pre-treat with AHK-Cu, GHK-Cu, or CuSO4 (matched copper, 1-100nM, 1 hour before H2O2). Measure: 8-OHdG (oxidative DNA damage) by immunofluorescence; protein carbonyl content (DNPH derivatisation, Western blot); and cell viability (calcein-AM/ethidium homodimer). Any difference in cytoprotection between AHK-Cu and GHK-Cu at matched copper concentrations characterises the N-terminal residue contribution to ATCUN copper peptide antioxidant biology in a physiologically relevant oxidative stress model.

The ATCUN motif's presence in numerous endogenous proteins — albumin (the N-terminus Asp-Ala-His constitutes a natural ATCUN sequence that binds the majority of plasma Cu(II)), histatins (salivary antimicrobial peptides with ATCUN sequences), and GHK itself released from collagen — suggests that ATCUN copper coordination is a physiologically important regulatory mechanism for copper distribution and delivery. AHK-Cu and GHK-Cu can be understood as synthetic mimics of this endogenous ATCUN copper biology, providing defined copper-peptide complexes for mechanistic research into how ATCUN-bound copper is transferred to copper-requiring enzymes (cuproenzymes including ceruloplasmin, SOD1, cytochrome c oxidase, lysyl oxidase). Copper chaperone research — studying how copper is transferred from ATCUN plasma carrier sites to intracellular chaperones (ATOX1, CCS, COX17) — can use AHK-Cu and GHK-Cu as defined extracellular copper sources with controlled copper speciation.

For analytical chemistry laboratories, AHK-Cu provides a well-defined ATCUN copper complex for method development and validation in copper-peptide quantification research. LC-MS/MS methods for ATCUN copper complexes require careful consideration of ionisation conditions — the Cu(II) complex is typically measured as the [M+H-Cu]+ species (peptide plus proton, minus copper) under positive ESI conditions because Cu(II) coordination is disrupted during electrospray ionisation at typical source voltages. Alternatively, negative ion mode ESI at low source energy can preserve the intact [M+Cu-2H]- species. Developing parallel positive and negative ion mode methods for AHK-Cu versus GHK-Cu and validating with synthetic standards provides the analytical foundation for copper peptide quantification in biological matrices — plasma, conditioned medium, or tissue homogenates — where copper peptide concentrations are in the low nanomolar range requiring highly sensitive and selective quantification methods.